cladribine | |
---|---|
Trade Name | |
Orphan Indication | Chronic lymphocytic leukemia |
USA Market Approval | USA |
USA Designation Date | 1990-12-31 00:00:00 |
Sponsor | Janssen Research & Development, LLC;Global Regulatory Affairs, 920 US Route 202;Raritan, New Jersey, 08869 |